Invesco Ltd. Immunity Bio, Inc. Transaction History

Invesco Ltd.

$600 Billion
Q3 2025

A detailed history of Invesco Ltd. transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 159,483 shares of IBRX stock, worth $331,724. This represents 0.0% of its overall portfolio holdings.

Number of Shares

159,483

Previous 130,151 22.54%

Holding current value

$331,724

Previous $343,000 14.29%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$2.24 - $3.01 $65,703 - $88,289	29,332 Added 22.54%	159,483 $392,000
Q2 2025 Aug 13, 2025	BUY	$1.89 - $3.44 $37,824 - $68,844	20,013 Added 18.17%	130,151 $343,000
Q1 2025 May 12, 2025	BUY	$2.32 - $3.9 $103,105 - $173,323	44,442 Added 67.65%	110,138 $331,000
Q4 2024 Feb 13, 2025	BUY	$2.56 - $6.17 $7,452 - $17,960	2,911 Added 4.64%	65,696 $168,000
Q3 2024 Nov 12, 2024	BUY	$3.32 - $6.7 $5,876 - $11,859	1,770 Added 2.9%	62,785 $232,000

Q2 2024 Aug 13, 2024	SELL	$4.82 - $9.15 $5.81 Million - $11 Million	-1,206,127 Reduced 95.18%	61,015 $385,000
Q1 2024 May 14, 2024	BUY	$3.23 - $6.17 $2.02 Million - $3.86 Million	625,779 Added 97.57%	1,267,142 $6.8 Million
Q4 2023 Feb 12, 2024	BUY	$1.25 - $5.21 $744,862 - $3.1 Million	595,890 Added 1310.43%	641,363 $3.22 Million
Q3 2023 Nov 13, 2023	BUY	$1.29 - $3.1 $1,021 - $2,455	792 Added 1.77%	45,473 $76,000
Q2 2023 Aug 11, 2023	BUY	$1.53 - $6.41 $3,748 - $15,704	2,450 Added 5.8%	44,681 $124,000
Q1 2023 May 12, 2023	SELL	$1.35 - $4.78 $392,343 - $1.39 Million	-290,625 Reduced 87.31%	42,231 $76,000
Q4 2022 Feb 13, 2023	BUY	$4.35 - $6.77 $1.27 Million - $1.97 Million	291,110 Added 697.34%	332,856 $1.69 Million
Q3 2022 Nov 14, 2022	BUY	$3.65 - $6.43 $9,833 - $17,322	2,694 Added 6.9%	41,746 $207,000
Q2 2022 Aug 15, 2022	BUY	$2.68 - $6.14 $8,961 - $20,532	3,344 Added 9.36%	39,052 $145,000
Q1 2022 May 16, 2022	BUY	$5.05 - $7.53 $12,604 - $18,794	2,496 Added 7.52%	35,708 $200,000
Q4 2021 Feb 14, 2022	SELL	$5.67 - $10.18 $44,140 - $79,251	-7,785 Reduced 18.99%	33,212 $202,000
Q3 2021 Nov 15, 2021	BUY	$9.17 - $14.24 $6,785 - $10,537	740 Added 1.84%	40,997 $399,000
Q2 2021 Aug 17, 2021	BUY	$13.41 - $22.4 $396,064 - $661,584	29,535 Added 275.46%	40,257 $575,000
Q1 2021 May 17, 2021	BUY	$12.83 - $42.25 $137,563 - $453,004	10,722 New	10,722 $254,000

Others Institutions Holding IBRX

# of Institutions

298

Shares Held

137M

Call Options Held

2.59M

Put Options Held

3.35M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $833M
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account